Company
Lynk Pharmaceuticals Co., Ltd
Lynk Pharmaceuticals Co., Ltd has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| LNK01001 | Phase 3 | Rheumatoid Arthritis |
Latest
No recent events.
Follow Lynk Pharmaceuticals Co., Ltd on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.